Fuqing Hospital
Welcome,         Profile    Billing    Logout  
 9 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chen, Ping
NCT04486651: HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer

Recruiting
3
560
RoW
Irinotecan Hydrochloride Injection, HX008, Placebo
Taizhou Hanzhong biomedical co. LTD
Stomach Cancer
08/23
08/23
G-HOPE-001, NCT06238843: A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma

Enrolling by invitation
3
450
RoW
irinotecan, IBI343, paclitaxel
Innovent Biologics (Suzhou) Co. Ltd.
Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
12/26
12/27
NCT05715931: Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Recruiting
2
30
RoW
Toripalimab, Trastuzumab, 5-FU, leucovorin, docetaxel, oxaliplatin (FLOT)
Yu jiren
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer
03/25
03/28
NCT06044350: A Clinical Trial of BAT4406F Injection in Patients with Neuromyelitis Optica Spectrum Disorders

Recruiting
2
162
RoW
BAT4406F Injection, BAT4406F Placebos
Bio-Thera Solutions
Optic Neuromyelitis Spectrum Disease
05/25
05/26
NCT05729646: Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Recruiting
2
90
RoW
Toripalimab, Oxaliplatin, S1
Yu jiren
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Mismatch Repair Deficiency
02/26
02/29
NCT05678270: A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Recruiting
2
70
RoW
ICP-192
Beijing InnoCare Pharma Tech Co., Ltd.
Intrahepatic Cholangiocarcinoma (ICC)
05/26
12/26
NCT05970627: Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Not yet recruiting
2
30
RoW
Toripalimab, Oxaliplatin, S1
Yu jiren
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma
07/26
07/29
TRS00501001, NCT05395533: A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL.

Recruiting
1
152
RoW
Recombinant CD20 monoclonal antibody-MMAE conjugte for injection, TRS005
Zhejiang Teruisi Pharmaceutical Inc.
CD20-positive B-cell Non-Hodgkin Lymphoma
12/23
12/24
CIBI343A101, NCT05458219: A First-in-human Study of IBI343 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors

Recruiting
1
470
US, RoW
IBI343
Innovent Biologics (Suzhou) Co. Ltd., Innovent Biologics, Inc., TigerMed
Locally Advanced Unresectable or Metastatic Solid Tumors
12/25
12/25
ESAPT, NCT05304455: Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection

Completed
N/A
40
RoW
Apixaban 2.5 MG, ELIQUIS, Dipyridamole 25Mg Tab, Persantine, subcutaneous Low Molecular Weight Heparin, LMWHs
Northern Jiangsu People's Hospital
Cirrhosis, Splenectomy, Venous Thrombosis, Hypertension, Portal
05/23
05/23
VNRSD, NCT05300516: Vagus Nerve-guided Robotic-assisted Splenectomy and Azygoportal Disconnection

Completed
N/A
60
RoW
vagus nerve-guided group
Northern Jiangsu People's Hospital
Cirrhosis, Hypertension, Splenectomy, Robotic-assisted
07/23
07/23
Sun, Fuqing
No trials found
Zheng, Qiaowen
No trials found
Lin, Kaijin
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chen, Ping
NCT04486651: HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer

Recruiting
3
560
RoW
Irinotecan Hydrochloride Injection, HX008, Placebo
Taizhou Hanzhong biomedical co. LTD
Stomach Cancer
08/23
08/23
G-HOPE-001, NCT06238843: A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma

Enrolling by invitation
3
450
RoW
irinotecan, IBI343, paclitaxel
Innovent Biologics (Suzhou) Co. Ltd.
Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
12/26
12/27
NCT05715931: Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Recruiting
2
30
RoW
Toripalimab, Trastuzumab, 5-FU, leucovorin, docetaxel, oxaliplatin (FLOT)
Yu jiren
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer
03/25
03/28
NCT06044350: A Clinical Trial of BAT4406F Injection in Patients with Neuromyelitis Optica Spectrum Disorders

Recruiting
2
162
RoW
BAT4406F Injection, BAT4406F Placebos
Bio-Thera Solutions
Optic Neuromyelitis Spectrum Disease
05/25
05/26
NCT05729646: Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Recruiting
2
90
RoW
Toripalimab, Oxaliplatin, S1
Yu jiren
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Mismatch Repair Deficiency
02/26
02/29
NCT05678270: A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Recruiting
2
70
RoW
ICP-192
Beijing InnoCare Pharma Tech Co., Ltd.
Intrahepatic Cholangiocarcinoma (ICC)
05/26
12/26
NCT05970627: Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Not yet recruiting
2
30
RoW
Toripalimab, Oxaliplatin, S1
Yu jiren
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma
07/26
07/29
TRS00501001, NCT05395533: A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL.

Recruiting
1
152
RoW
Recombinant CD20 monoclonal antibody-MMAE conjugte for injection, TRS005
Zhejiang Teruisi Pharmaceutical Inc.
CD20-positive B-cell Non-Hodgkin Lymphoma
12/23
12/24
CIBI343A101, NCT05458219: A First-in-human Study of IBI343 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors

Recruiting
1
470
US, RoW
IBI343
Innovent Biologics (Suzhou) Co. Ltd., Innovent Biologics, Inc., TigerMed
Locally Advanced Unresectable or Metastatic Solid Tumors
12/25
12/25
ESAPT, NCT05304455: Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection

Completed
N/A
40
RoW
Apixaban 2.5 MG, ELIQUIS, Dipyridamole 25Mg Tab, Persantine, subcutaneous Low Molecular Weight Heparin, LMWHs
Northern Jiangsu People's Hospital
Cirrhosis, Splenectomy, Venous Thrombosis, Hypertension, Portal
05/23
05/23
VNRSD, NCT05300516: Vagus Nerve-guided Robotic-assisted Splenectomy and Azygoportal Disconnection

Completed
N/A
60
RoW
vagus nerve-guided group
Northern Jiangsu People's Hospital
Cirrhosis, Hypertension, Splenectomy, Robotic-assisted
07/23
07/23
Sun, Fuqing
No trials found
Zheng, Qiaowen
No trials found
Lin, Kaijin
No trials found

Download Options